Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TNG.PAthis companyTransgene S.A.	€0.74	-3.69×	1.14×	282.76×	-3.37×	-99.9%	100.0%	-8381.6%	-7658.0%	-30.8%	-27.4%	-27.1%	0.02×	0.12×	-24.29×	9.62×	0.0%	3	6.94	2	C+
ALCLS.PACellectis S.A.	€1.05	-7.05×	6.52×	6.52×	-24.8×	-443.6%	72.5%	-55.3%	-92.7%	-92.7%	-19.9%	-8.9%	1.2×	-1.38×	-4.98×	1.62×	0.0%	2	-1.71	1	D+
ALNEV.PANeovacs S.A.	€0.09	-669.23×	180.66×	20,138.85×	-621.56×	-102.4%	-2796.5%	-3354.8%	-3026.8%	-27.2%	-24.6%	-0.2%	0.03×	0.01×	-5.79×	0.84×	0.0%	3	-4.72	1	C-
ALALTME.PATME Pharma N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ALVIO.PAValerio Therapeutics S.A.	€0.49	-4.35×	10.27×	8.28×	51.4×	-135.2%	67.1%	-21.4%	-190.4%	-236.0%	-5.5%	2.4%	3.67×	12.09×	-1.96×	0.76×	0.0%	6	5.8	2	C
IPH.PAInnate Pharma S.A.	€1.31	-2.91×	-6.59×	51.33×	-2.46×	-112.1%	100.0%	-2058.0%	-1764.5%	226.6%	-146.1%	-37.0%	-1.04×	0.1×	-18.38×	1.27×	0.0%	3	-22.95	2	C
Peer median	—	-5.7×	8.39×	29.81×	-13.63×	-123.7%	69.8%	-1056.7%	-977.4%	-59.9%	-22.3%	-4.5%	0.61×	0.05×	-5.38×	1.06×	0.0%	3	-3.21	2	—